Cargando…

The P2X7 Receptor and NLRP3 Axis in Non-Alcoholic Fatty Liver Disease: A Brief Review

Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease worldwide, and its prevalence is reaching epidemic characteristics both in adults and in children. The increase of NAFLD prevalence parallels that of obesity, now representing the major cause of liver inflammation, increasing...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rossato, Marco, Di Vincenzo, Angelo, Pagano, Claudio, Hadi, Hamza El, Vettor, Roberto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226571/ https://www.ncbi.nlm.nih.gov/pubmed/32331389 http://dx.doi.org/10.3390/cells9041047

Ejemplares similares

Cardio-Metabolic Disorders in Non-Alcoholic Fatty Liver Disease
por: El Hadi, Hamza, et al.
Publicado: (2019)

Vitamin E as a Treatment for Nonalcoholic Fatty Liver Disease: Reality or Myth?
por: Hadi, Hamza El, et al.
Publicado: (2018)

Antioxidant, Anti-Inflammatory, and Metabolic Properties of Tocopherols and Tocotrienols: Clinical Implications for Vitamin E Supplementation in Diabetic Kidney Disease
por: Di Vincenzo, Angelo, et al.
Publicado: (2019)

Relationship between Heart Disease and Liver Disease: A Two-Way Street
por: El Hadi, Hamza, et al.
Publicado: (2020)

Food Ingredients Involved in White-to-Brown Adipose Tissue Conversion and in Calorie Burning
por: El Hadi, Hamza, et al.
Publicado: (2019)

Non-aromatizable androgens modulate the lipopolysaccharide induced expression of the P2X7 receptor in human adipocytes
por: Di Vincenzo, Angelo, et al.
Publicado: (2023)

SAT-108 Effects of Bariatric and Non-Bariatric Weight Loss on Migraine Headache in Obesity. A Systematic Review and Meta-Analysis
por: Di Vincenzo, Angelo, et al.
Publicado: (2019)

Cardiovascular Risk in Non-Alcoholic Fatty Liver Disease: Mechanisms and Therapeutic Implications
por: Tana, Claudio, et al.
Publicado: (2019)

COVID-19 and Smoking: An Opportunity to Quit… When Vaccinated!
por: Rossato, Marco, et al.
Publicado: (2022)

SAT-LB98 Early Atherosclerosis in Polycystic Ovary Syndrome. a Systematic Review, Meta-Analysis and Meta-Regression
por: Parolin, Matteo, et al.
Publicado: (2020)

Obesity, Male Reproductive Function and Bariatric Surgery
por: Di Vincenzo, Angelo, et al.
Publicado: (2018)

Association of obstructive sleep apnea with non-alcoholic fatty liver disease in patients with obesity: an observational study
por: Bettini, Silvia, et al.
Publicado: (2021)

Dihydrotestosterone, and Not Testosterone, Enhances the LPS-Induced Inflammatory Cytokine Gene Expression in Human Adipocytes
por: Di Vincenzo, Angelo, et al.
Publicado: (2023)

Involvement of the P2X7-NLRP3 axis in leukemic cell proliferation and death
por: Salaro, Erica, et al.
Publicado: (2016)

Current smoking is not associated with COVID-19
por: Rossato, Marco, et al.
Publicado: (2020)

The Purinergic P2X7 Receptor-NLRP3 Inflammasome Pathway: A New Target in Alcoholic Liver Disease?
por: Le Daré, Brendan, et al.
Publicado: (2021)

Insulin Stimulates IL-23 Expression in Human Adipocytes: A Possible Explanation for the Higher Prevalence of Psoriasis in Obesity
por: Di Vincenzo, Angelo, et al.
Publicado: (2023)

Gut–Liver Axis Derangement in Non-Alcoholic Fatty Liver Disease
por: Poeta, Marco, et al.
Publicado: (2017)

Contrasting Effects of Fasting on Liver-Adipose Axis in Alcohol-Associated and Non-alcoholic Fatty Liver
por: Rasineni, Karuna, et al.
Publicado: (2021)

The NLRP3 Inflammasome in Non-Alcoholic Fatty Liver Disease and Steatohepatitis: Therapeutic Targets and Treatment
por: Yu, Lili, et al.
Publicado: (2022)

Modulation of serotonin in the gut-liver neural axis ameliorates the fatty and fibrotic changes in non-alcoholic fatty liver
por: Ko, Masayoshi, et al.
Publicado: (2021)

Estrogen and COVID-19: friend or foe?
por: Di Vincenzo, A., et al.
Publicado: (2021)

Apigenin attenuates atherosclerosis and non-alcoholic fatty liver disease through inhibition of NLRP3 inflammasome in mice
por: Lu, Zheng, et al.
Publicado: (2023)

Correction: Modulation of serotonin in the gut-liver neural axis ameliorates the fatty and fibrotic changes in non-alcoholic fatty liver
por: Ko, Masayoshi, et al.
Publicado: (2023)

Targeting Liver X Receptors for the Treatment of Non-Alcoholic Fatty Liver Disease
por: Kim, Hyejin, et al.
Publicado: (2023)

Body Weight Reduction by Bariatric Surgery Reduces the Plasma Levels of the Novel Orexigenic Gut Hormone Insulin-like Peptide 5 in Patients with Severe Obesity
por: Di Vincenzo, Angelo, et al.
Publicado: (2023)

P2X7 Receptor in Alcoholic Steatohepatitis and Alcoholic Liver Fibrosis
por: Xia, Guo-Qing, et al.
Publicado: (2022)

Somatotropic Axis Dysfunction in Non-Alcoholic Fatty Liver Disease: Beneficial Hepatic and Systemic Effects of Hormone Supplementation
por: Cabrera, Daniel, et al.
Publicado: (2018)

Amelioratory Effect of Resistant Starch on Non-alcoholic Fatty Liver Disease via the Gut-Liver Axis
por: Zhu, Weifeng, et al.
Publicado: (2022)

New Insights into Non-Alcoholic Fatty Liver Disease and Coronary Artery Disease: The Liver-Heart Axis
por: Cazac, Georgiana-Diana, et al.
Publicado: (2022)

Gegen Qinlian Decoction Ameliorates Nonalcoholic Fatty Liver Disease in Rats via Oxidative Stress, Inflammation, and the NLRP3 Signal Axis
por: Ying, Yuqi, et al.
Publicado: (2021)

Diet, Gut Microbiota and Non-Alcoholic Fatty Liver Disease: Three Parts of the Same Axis
por: Quesada-Vázquez, Sergio, et al.
Publicado: (2020)

The Role of Gut Microbiota-Bile Acids Axis in the Progression of Non-alcoholic Fatty Liver Disease
por: Ni, Yiming, et al.
Publicado: (2022)

Molecular and Pharmacological Evidence for the Expression of Multiple Functional P2 Purinergic Receptors in Human Adipocytes
por: Rossato, Marco, et al.
Publicado: (2022)

Naturally Occurring Stilbenoid TSG Reverses Non-Alcoholic Fatty Liver Diseases via Gut-Liver Axis
por: Lin, Pei, et al.
Publicado: (2015)

“Liver–gut” axis: A target of traditional Chinese medicine for the treatment of non-alcoholic fatty liver disease
por: Guo, Kangxiao, et al.
Publicado: (2022)

An Animal Model for the Juvenile Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis
por: Marin, Veronica, et al.
Publicado: (2016)

Relationship between Non-Alcoholic Fatty Liver Disease and Psoriasis: A Novel Hepato-Dermal Axis?
por: Mantovani, Alessandro, et al.
Publicado: (2016)

Dietary patterns and risk of non-alcoholic fatty liver disease
por: Salehi-sahlabadi, Ammar, et al.
Publicado: (2021)

NLRP3: a new therapeutic target in alcoholic liver disease
por: Brahadeeswaran, Subhashini, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_o8o6uerchm3nmlrfetiir2gqif